Clinical Trials List
2018-01-01 - 2023-12-18
Phase I
Terminated5
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Han-Lin Hsu Division of Hematology & Oncology
- Ming-Shun Wu Division of Hematology & Oncology
- Chih-Shiang Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yao-Yu Hsieh Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Min Yeh Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- 蘇文 彬 Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳佳宏 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
0 participants
